XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative adjustment
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Retained Earnings
Retained Earnings
Cumulative adjustment
Beginning balance (in shares) at Dec. 31, 2022     230,866        
Beginning balance at Dec. 31, 2022 $ 5,454,557   $ 2 $ 3,767,686 $ (38,606) $ 1,725,475  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of equity instruments as consideration for business combination (in shares)     961        
Issuance of equity instruments as consideration for business combinations 44,995     44,995      
Issuance of common stock upon settlement of stock awards, net of shares withheld (in shares)     1,955        
Issuance of common stock upon settlement of stock awards, net of shares withheld (62,497)     (62,497)      
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)     713        
Issuance of common stock upon exercise of stock options, net of repurchases 9,566     9,566      
Stock-based compensation expense 212,982     212,982      
Stock-based compensation expense recognized in relation to restructuring 84,042     84,042      
Comprehensive income (loss) 10,197       10,197    
Net income (loss) (78,896)         (78,896)  
Ending balance (in shares) at Mar. 31, 2023     234,495        
Ending balance at Mar. 31, 2023 5,674,946   $ 2 4,056,774 (28,409) 1,646,579  
Beginning balance (in shares) at Dec. 31, 2022     230,866        
Beginning balance at Dec. 31, 2022 $ 5,454,557   $ 2 3,767,686 (38,606) 1,725,475  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accounting standards update Accounting Standards Update 2023-08 [Member]            
Ending balance (in shares) at Dec. 31, 2023     242,048        
Ending balance at Dec. 31, 2023 $ 6,281,649 $ 561,489 $ 2 4,491,571 (30,270) 1,820,346 $ 561,489
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon settlement of stock awards, net of shares withheld (in shares)     999        
Issuance of common stock upon settlement of stock awards, net of shares withheld $ (117,225)     (117,225)      
Issuance of common stock upon exercise of stock options, net of repurchases (in shares) 2,338   2,324        
Issuance of common stock upon exercise of stock options, net of repurchases $ 44,603     44,603      
Stock-based compensation expense 235,569     235,569      
Purchase of capped calls (104,110)     (104,110)      
Comprehensive income (loss) (7,226)       (7,226)    
Net income (loss) 1,176,245         1,176,245  
Ending balance (in shares) at Mar. 31, 2024     245,371        
Ending balance at Mar. 31, 2024 $ 8,070,994   $ 2 $ 4,550,408 $ (37,496) $ 3,558,080